What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA approved the first oral treatment option for the autoimmune disorder dermatomyositis. Brepocitinib (Lisraya) is indicated for adults with the rare condition, which causes chronic inflammation, progressive muscle weakness...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Precancerous blood cells can actively reshape their surroundings, prematurely aging cells in the bone marrow to create conditions that favor their own growth and potentially increase the risk of blood…
(MedPage Today) -- Hormone replacement therapy (HRT) was tied to a lower risk of dementia in a prospective study of nearly 185,000 postmenopausal women in the U.K. Biobank.
Zoomlion Ghana Limited has begun a week-long disinfection and disinfestation exercise across all 15 municipalities and districts in the Upper East Region to help prevent disease outbreaks during the…
The shots have been approved for people 65 and older, and for younger people with underlying conditions. Others may be able to get them off label.
(MedPage Today) -- In the wake of two measles-associated deaths in Pennsylvania, including an infant, Health Secretary Robert F. Kennedy Jr.
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
